Total Payments
$2,456
2024 Payments
$1,567
Companies
17
Transactions
90
Medicare Patients
5,043
Medicare Billing
$389,785
Payment Breakdown by Category
Food & Beverage$2,276 (92.7%)
Education$179.98 (7.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,276 | 88 | 92.7% |
| Education | $179.98 | 2 | 7.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $653.09 | 18 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $497.36 | 24 | $0 (2024) |
| Lilly USA, LLC | $247.01 | 11 | $0 (2024) |
| ABBVIE INC. | $240.82 | 11 | $0 (2024) |
| Allergan, Inc. | $221.56 | 4 | $0 (2022) |
| Galderma Laboratories, L.P. | $128.97 | 3 | $0 (2024) |
| UCB, Inc. | $121.68 | 4 | $0 (2024) |
| Amgen Inc. | $90.92 | 4 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $48.37 | 2 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $42.72 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,567 | 60 | Janssen Biotech, Inc. ($591.08) |
| 2023 | $346.84 | 14 | E.R. Squibb & Sons, L.L.C. ($107.91) |
| 2022 | $347.02 | 10 | Allergan, Inc. ($221.56) |
| 2020 | $83.74 | 1 | Galderma Laboratories, L.P. ($83.74) |
| 2019 | $111.09 | 5 | AbbVie, Inc. ($40.67) |
All Payment Transactions
90 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $19.32 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $26.62 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: Immunology | ||||||
| 12/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: Immunology | ||||||
| 11/25/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $25.56 | General |
| Category: Immunology | ||||||
| 11/22/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: Inflammation | ||||||
| 11/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $28.06 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $3.01 | General |
| Category: Immunology | ||||||
| 11/15/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: Immunology | ||||||
| 11/08/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $7.22 | General |
| Category: Immunology | ||||||
| 10/29/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: IMMUNOLOGY | ||||||
| 10/28/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $29.97 | General |
| Category: Immunology | ||||||
| 10/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Immunology | ||||||
| 10/21/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: Inflammation | ||||||
| 10/21/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $4.90 | General |
| Category: Immunology | ||||||
| 10/18/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $23.30 | General |
| Category: Immunology | ||||||
| 10/08/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $25.54 | General |
| Category: Inflammation | ||||||
| 10/04/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | BLU-U (Medical Supply) | Food and Beverage | In-kind items and services | $27.91 | General |
| Category: Dermatology | ||||||
| 10/01/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: Immunology | ||||||
| 09/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: IMMUNOLOGY | ||||||
| 09/23/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $3.27 | General |
| Category: Immunology | ||||||
| 09/06/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $32.73 | General |
| Category: Immunology | ||||||
| 08/27/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.11 | General |
| Category: Immunology | ||||||
| 08/27/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $20.00 | General |
| 08/20/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,194 | 2,385 | $410,101 | $92,050 |
| 2022 | 11 | 1,330 | 2,395 | $430,825 | $97,788 |
| 2021 | 12 | 1,405 | 2,475 | $504,488 | $119,024 |
| 2020 | 12 | 1,114 | 1,795 | $395,705 | $80,923 |
Total Patients
5,043
Total Services
9,050
Medicare Billing
$389,785
Procedure Codes
48
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 267 | 337 | $87,362 | $22,730 | 26.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 156 | 198 | $69,588 | $15,693 | 22.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 234 | 329 | $71,496 | $13,920 | 19.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 80 | 99 | $37,110 | $9,293 | 25.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 88 | 100 | $34,060 | $8,812 | 25.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 179 | 1,050 | $43,374 | $5,853 | 13.5% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 48 | 95 | $18,105 | $4,234 | 23.4% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 16 | 18 | $10,500 | $2,725 | 25.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 32 | 32 | $11,218 | $2,667 | 23.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 57 | 62 | $9,972 | $2,315 | 23.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $7,197 | $1,897 | 26.4% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 11 | 39 | $6,919 | $1,384 | 20.0% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 11 | 11 | $3,200 | $526.72 | 16.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 328 | 438 | $108,240 | $29,226 | 27.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 175 | 225 | $81,302 | $17,905 | 22.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 246 | 329 | $73,096 | $14,094 | 19.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 80 | 108 | $36,920 | $9,449 | 25.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 135 | 154 | $24,836 | $6,784 | 27.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 177 | 896 | $37,816 | $5,157 | 13.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 67 | 117 | $22,991 | $5,139 | 22.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 40 | 45 | $15,975 | $4,273 | 26.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 45 | 45 | $15,840 | $3,176 | 20.1% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 15 | 16 | $7,559 | $1,389 | 18.4% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 22 | 22 | $6,250 | $1,195 | 19.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 340 | 492 | $120,936 | $35,430 | 29.3% |
About Dr. Melissa Michelon, MD
Dr. Melissa Michelon, MD is a Dermatology healthcare provider based in Worcester, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/04/2011. The National Provider Identifier (NPI) number assigned to this provider is 1982983235.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Melissa Michelon, MD has received a total of $2,456 in payments from pharmaceutical and medical device companies, with $1,567 received in 2024. These payments were reported across 90 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($2,276).
As a Medicare-enrolled provider, Michelon has provided services to 5,043 Medicare beneficiaries, totaling 9,050 services with total Medicare billing of $389,785. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Worcester, MA
- Active Since 08/04/2011
- Last Updated 11/17/2020
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1982983235
Products in Payments
- Sotyktu (Drug) $497.36
- TREMFYA (Drug) $490.38
- BOTOX (Biological) $221.56
- TALTZ (Drug) $204.08
- SIMPONI ARIA (Biological) $129.03
- SKYRIZI (Biological) $108.84
- Bimzelx (Biological) $97.69
- Otezla (Drug) $90.92
- DUPIXENT (Biological) $54.71
- Zoryve (Drug) $42.72
- Humira (Biological) $40.67
- REMICADE (Biological) $33.68
- AMELUZ (Drug) $29.42
- BLU-U (Medical Supply) $27.91
- Cimzia (Drug) $23.99
- YCANTH (Drug) $22.79
- HUMIRA (Biological) $21.93
- COSENTYX (Biological) $20.83
- Winlevi (Drug) $20.46
- OLUMIANT (Drug) $18.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Worcester
John Harris, Md, MD
Dermatology — Payments: $15.0M
Dermatology $15.0M
Seth Kates, M.d, M.D
Dermatology — Payments: $79,282
Dermatology $79,282
Mehdi Rashighi Firoozabadi, M.d, M.D
Dermatology — Payments: $13,000
Dermatology $13,000
Dr. Diana Reusch, Md, MD
Dermatology — Payments: $8,692
Dermatology $8,692
Christina Alavian, M.d, M.D
Dermatology — Payments: $2,163
Dermatology $2,163
Dr. Ryan Svoboda, M.d, M.D
Dermatology — Payments: $1,408
Dermatology $1,408